This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nguyen, L. N. Articles by Parks, W. T. Search for Related Content PubMed PubMed Citation Articles by Nguyen, L. N. Articles by Parks, W. T.

Sorting Nexin 1 Down-Regulation Promotes Colon Tumorigenesis

Authors' Affiliations: ¹ Department of Pathology, University of Washington, Seattle, Washington; ² Department of Immunology, Baylor College of Medicine, Houston, Texas; and ³ Centro de Investigaciones Oncológicas (CIO-FUCA), Buenos Aires, Argentina

Requests for reprints: W. Tony Parks, Department of Pathology, HSB E506, University of Washington, Seattle, WA 98195. Phone: 206-543-4317; Fax: 206-543-3644; E-mail: parkst{at}u.washington.edu.

Purpose: Colon cancer is one of the most common human malignancies, yet studies have only begun to identify the multiple mechanisms that underlie the development of this tumor. In this study, we have identified a novel mechanism, dysregulation of endocytic sorting, which promotes colon cancer development.

Experimental Design: Immunohistochemical and microarray analyses were done on human colon cancer tissue specimens to determine the levels of one endocytic protein, sorting nexin 1 (SNX1). SW480 cells, a human colon cancer cell line that retains a relatively high level of SNX1 expression, were used to assess the effects of down-regulating this protein by small hairpin RNA. Activation of signal transduction cascades was evaluated in these cells using Western blotting, and multiple functional assays were done.

Results: We determined by immunohistochemistry that the level of SNX1 was significantly down-regulated in 75% of human colon cancers. In corroborative studies using microarray analysis, SNX1 message was significantly decreased (log₂ ratio less than –1) for 8 of 19 colon carcinomas. Cell lines with reduced SNX1 levels showed increased proliferation, decreased apoptosis, and decreased susceptibility to anoikis. They also showed increased activation of epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 in response to epidermal growth factor. This increased activation was abolished by inhibition of endocytosis.

Conclusions: These data suggest that loss of SNX1 may play a significant role in the development and aggressiveness of human colon cancer, at least partially through the mechanism of increased signaling from endosomes. Further, these findings suggest that dysregulation of endocytic proteins may represent a new paradigm in the process of carcinogenesis.